Houston Methodist Part of National Consortium to Develop Vaccine Against Herpesviruses
Houston Methodist researchers will be part of a national consortium funded by an up to $49 million award from the U.S. Government’s Advanced Research Projects Agency for Health (ARPA-H) to develop a vaccine against two of the most common and...
3-Oct-2024 7:05 PM EDT
Add to Favorites